Low-Pressure Stopcocks Segment Dominated North America Advanced Medical Stopcock Market in 2021
According to The Insight Partners research study, titled "North America Advanced Medical Stopcock Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type and End User," the market is valued at US$ 335.94 million in 2021 and is estimated to reach US$ 430.56 million by 2028; it is expected to grow at a CAGR of 3.7% from 2022 to 2028. The growing incidence of chronic diseases and a surge in the number of surgical procedures are the factors that contribute to the North America advanced medical stopcock market growth. However, the safety concerns regarding stopcocks are restricting the market growth.
IV Therapy to Bolster North America Advanced Medical Stopcock Market during Forecast Period. Intravenous (IV) therapy is commonly administered to receive medications or fluids. One of the major benefits of using IV infusion therapy is the fast delivery of medication/nutrients into the patient’s body. IV infusion therapy can be completed within an hour, allowing the nutrients/medications to be transferred directly into the patient’s blood. It is used as a treatment for several medical conditions that do not allow sufficient absorption of nutrition, vitamins, and minerals. Further, IV infusion therapy also provides instant rehydration. IV fluids are highly recommended for patients suffering from a fluid volume deficit. Moreover, drug treatments or physical therapy usually cannot be modified as they are specifically designed to treat certain conditions. However, healthcare professionals can modify the treatment with IV infusions depending on their needs. If the patient suffers from fatigue, allergies, or other medical impairment, the customizable nature of IV therapy can help improve such issues. Thus, with the growing popularity of IV therapy owing to its advantages, the market for advanced medical stopcock in North America is expected to grow over the forecast period.
North America Advanced Medical Stopcock Market, by Country, 2021 (%)
North America Advanced Medical Stopcock Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Low-Pressure Stopcocks, Medium Pressure Stopcocks, and High-Pressure Stopcocks) and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Homecare) 
North America Advanced Medical Stopcock Market to Grow at a CAGR of 3.7% to reach US$ 430.56 million by from 2022 to 2028
Download Free Sample
Source: The Insight Partners Analysis
Impact of COVID-19 Pandemic on Advanced Medical Stopcock Market
In 2021, the US FDA authorized an emergency use authorization (EUA) monoclonal antibody Intravenous (IV) therapy for COVID-19 patients suffering from mild to moderate symptoms. IV therapy administers medicines directly into the patient’s bloodstream with the help of stopcocks. Monoclonal antibodies block viral attachment and entry into human cells to neutralize SARS-CoV-2. Also, in November 2020, the FDA approved a EUA for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19. Also, IV vitamin drips were administered to COVID-19 patients for faster recovery. Thus, the growing number of FDA-approved infusion therapy and IV drips for the treatment of COVID-19 is supporting the North America advanced medical stopcock market.
Based on type, the North America advanced medical stopcock market is segmented into low-pressure stopcocks, medium-pressure stopcocks, and high-pressure stopcocks. The low-pressure stopcocks segment held the largest share of the market in 2021, and it is expected to register the highest CAGR during the forecast period. The low-pressure stopcocks are designed to control the flow of a liquid or gas by using an on/off diverter cock. The pressure of the low-pressure stopcock is 200 psi. These stopcocks offer various advantages such as accuracy, convenience, and flow control per the requirement. The low-pressure stopcock is available in one-way, two-way, and three-way configurations. These enable inserting different fluids in different ways. The low-pressure stopcocks are used in medical and laboratory practices and enable the treatment of patients who require an accurate flow of medicines. Nordson Corporation; Qosina; Navilyst Medical, Inc; and Medline Industries, Inc are a few of the major players operating in the North America advanced medical stopcock market. The rise in the prevalence of chronic health conditions is likely to increase the demand for low-pressure stopcocks during the forecast period.
B. Braun Melsungen AG, Smiths Medical Inc, Nipro Corp, Elcam Medical Group Co, Merit Medical Systems Inc, CODAN US Corp, Nordson Corp, Cook Medical LLC, JCM MED SaRL, and Utah Medical Products Inc are the key companies operating in the North America advanced medical stopcock market.
The report segments the North America advanced medical stopcock market as follows:
The North America advanced medical stopcock market is segmented on the basis of type, end user, and country. Based on type, the market is segmented into low-pressure stopcocks, medium-pressure stopcocks, and high-pressure stopcocks. Based on end user, the North America advanced medical stopcocks market is segmented into hospitals & clinics, homecare, and ambulatory surgery centers. By country, the market is segmented into the US, Canada, and Mexico.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com